Brighten recommends labs most primary care visits skip: fasting insulin, HbA1c, lipids, CRP, DEXA, full thyroid panel, estradiol, testosterone, SHBG, DHEA-S
Semaglutide-based clinical evidence from a post hoc analysis of the SUSTAIN (Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes) trials (SUSTAIN 15
The Role of Secondary Bile Acids in Intestinal Inflammation (2023)
And theyre well-positioned at that point to receive them.
Given the steep costs and high demand for these drugs, employers and insurers may continue to impose more restrictive eligibility standards for coverage than the clinical indications set by the Food and Drug Administration